血管ステントシステム市場レポート：2031年までの動向、予測、競合分析

世界の血管ステントシステム市場の将来は、静脈と動脈市場に機会がありそうです。世界の血管ステントシステム市場は、2025年から2031年にかけてCAGR 6.9％で成長すると予想されています。この市場の主な促進要因は、心血管疾患の有病率の上昇、ステント技術の進歩、高齢化です。

• Lucintelの予測では、タイプ別では120mmが予測期間中も最大セグメントであり続けるが、これは120mmが、より長期のステント留置を必要とする大規模または複雑な血管状態の治療用に設計されているためです。
• 用途別では、心臓から体内へ高い圧力で血液を送る動脈が引き続き大きなセグメントとなると思われます。
• 地域別では、革新的な医療技術の採用が多い北米が予測期間中に最も高い成長を遂げると予想されます。

150ページを超える包括的なレポートで、ビジネス上の意思決定に役立つ貴重な洞察を得ることができます。いくつかの洞察を含むサンプル図を以下に示します。

血管ステントシステム市場の新たな動向

世界の血管ステントシステム市場は、技術の進歩、個別化治療に対する需要の増加、規制状況の変化により変化しています。こうした新たな動向は、患者の転帰の改善、手技の効率化、市場アクセスの拡大に焦点を当てています。

• 生体吸収性ステント：生体吸収性ステントは、目的を果たすと体内で自然に溶解し、主要な動向として注目を集めています。これらのステントは恒久的なインプラントを必要としないため、恒久的なステントシステムに伴う合併症が軽減されます。このステントは、特に一時的な血管支持を必要とする若年患者に対する心血管系インターベンションの将来における主要な担い手のひとつとなると思われます。技術の成熟に伴い、より安全で効果的な治療オプションに対する需要の高まりから、生体吸収性ステントはより多くの市場シェアを獲得することになると思われます。
• 薬剤溶出ステント（DES）：薬剤溶出ステント（DES）は、動脈に直接薬剤を投与することで再狭窄のリスクを大幅に低減するため、血管ステント市場における重要な開発品です。DESは患者の予後を改善し、再手術を最小限にすることが示されているため、今日広く使用されています。市場が成熟するにつれて、ドラッグデリバリーをさらに強化し、副作用を軽減し、ステントの寿命を延長する新しいDES技術が開発されています。この動向により、多様な患者集団にDESが広く採用されるようになると予想されます。
• 低侵襲技術とロボット工学：ロボット工学とハイエンド画像処理による低侵襲手術が血管ステント市場の様相を変えつつあります。ロボット支援手術は、患者の回復時間と手術リスクを軽減しながら、より優れた精度と正確性を提供します。これらの技術により、より複雑な症例が効率的な方法で、合併症を少なくして治療できるようになります。この需要が拡大し続ける中、ステントシステムにはロボットシステムとの互換性やさらなる視覚誘導技術を取り入れた技術革新が期待されています。
• ステントデザインのカスタマイズと個別化：血管疾患の解明が進むにつれて、個々の患者のニーズに合わせたカスタムデザインのステントソリューションが台頭しています。動脈の大きさ、疾患の進行度、患者の健康状態などの要素を考慮したステントの個別化設計が増加しています。これにより、解剖学的および臨床的な問題に合わせてステントをカスタマイズすることで、より良好な結果が得られる可能性があります。このような個別化医療の動向は、患者固有のステントを設計するための多くの研究を推進し、市場規模を拡大すると予想されます。
• ステント材料の新開発：材料の革新も血管ステント市場の重要な動向のひとつで、合併症を引き起こしにくい生体適合性の高いステントの設計を研究しており、現在も調査中です。生分解性ポリマーや先端合金などの新素材は、ステントの性能と安全性を高めるために開発されています。新素材は再狭窄率を低下させ、様々な血管処置におけるステントの効率を向上させる可能性を秘めています。先端材料の使用により、ステント留置術の長期的な成功と患者の満足度が向上することが期待されます。

生体吸収性ステント、薬剤溶出ステント、低侵襲技術、個別化されたステント設計、使用材料の改良などの新しい動向は、世界中の血管ステントシステム市場に革命をもたらしています。新製品と新技術は治療成績の改善を通じて患者に恩恵をもたらし、ステント治療へのアクセスを増加させ、世界中のヘルスケア提供システムにおいて効率的で効果的な治療を保証すると期待されています。

血管ステントシステム市場の最近の動向

血管ステントシステム市場における最新の開発は、先進的で患者に優しいソリューションへの動向を反映しています。技術革新、規制の進展、業界との提携を通じて、より安全で効果的、かつコスト効率の高いステントの開発に重点が置かれています。

• 生体吸収性ステントの進歩：血管ステント市場における最も重要な進歩のひとつが生体吸収性ステントで、これは時間の経過とともに体内に吸収されます。このステントは血管を一時的に支え、長期的な合併症を最小限に抑え、再手術の必要性を減らします。技術が成熟し、臨床結果が有望視され続けるにつれて、生体吸収性ステントは市場でより大きなシェアを占めるようになると予想されます。
• 次世代薬剤溶出ステント：主な分野のひとつに次世代薬剤溶出ステント（DES）の開発があります。これらのステントは患部の動脈に直接薬剤を送り込むことで、再狭窄を予防し、患者の長期予後を改善します。新しいDESのデザインには、より効果的な薬剤やポリマーが含まれており、ステントの合併症軽減能力を高めているため、冠動脈疾患患者にとって最適な選択肢となっています。
• ロボット支援によるステント留置：ロボット支援ステント留置術は、ステント留置術の精度と安全性を向上させました。外科医はステント留置を比較的正確に行うことができるようになり、合併症のリスクも低く、回復時間も短縮されました。この技術がより利用しやすくなり、価格も手頃になるにつれて、この医療行為は多くの高級施設や低リソースの環境でも行われるようになると思われます。
• 規制当局の承認強化：FDAやEMAなどの規制機関は、革新的なステントシステムの承認プロセスを合理化し、より迅速な市場参入を可能にしています。このような規制当局の支援は、臨床転帰を改善する新しいステント技術の開発をメーカーに促しています。承認の迅速化によって技術革新が加速し、先進的なステントシステムがより効率的に患者に提供されるようになりました。
• ステント製造の世界的拡大：特に新興市場におけるステント製造能力の拡大により、世界中でより安価なステント選択肢を利用できるようになりました。メーカー各社はアジアやラテンアメリカなどの地域に生産施設を設立し、現地の需要の増加や競合の激化に対応するとともに、高品質のステントシステムをより多くの患者が利用できるようにしています。

生体吸収性ステント、薬剤溶出性ステント、ロボット支援手術、規制の改善、世界市場への製造進出といった最近の進歩が血管ステントシステム市場の成長を後押ししています。これらの技術革新は患者の治療の質を向上させ、治療へのアクセスを増加させ、血管インターベンションの未来を変えます。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 背景と分類
• サプライチェーン

第3章 市場動向と予測分析

• マクロ経済の動向と予測
• 業界の促進要因と課題
• PESTLE分析
• 特許分析
• 規制環境

第4章 血管ステントシステム市場：タイプ別

• 概要
• タイプ別の魅力分析
• 60 mm：動向と予測（2019年～2031年）
• 80 mm：動向と予測（2019年～2031年）
• 100 mm：動向と予測（2019年～2031年）
• 120 mm：動向と予測（2019年～2031年）
• その他：動向と予測（2019年～2031年）

第5章 血管ステントシステム市場：用途別

• 概要
• 用途別の魅力分析
• 静脈：動向と予測（2019年～2031年）
• 動脈：動向と予測（2019年～2031年）

第6章 地域分析

• 概要
• 血管ステントシステム市場：地域別

第7章 北米の血管ステントシステム市場

• 概要
• 北米の血管ステントシステム市場：タイプ別
• 北米の血管ステントシステム市場：用途別
• 米国の血管ステントシステム市場
• メキシコの血管ステントシステム市場
• カナダの血管ステントシステム市場

第8章 欧州の血管ステントシステム市場

• 概要
• 欧州の血管ステントシステム市場：タイプ別
• 欧州の血管ステントシステム市場：用途別
• ドイツの血管ステントシステム市場
• フランスの血管ステントシステム市場
• スペインの血管ステントシステム市場
• イタリアの血管ステントシステム市場
• 英国の血管ステントシステム市場

第9章 アジア太平洋の血管ステントシステム市場

• 概要
• アジア太平洋の血管ステントシステム市場：タイプ別
• アジア太平洋の血管ステントシステム市場：用途別
• 日本の血管ステントシステム市場
• インドの血管ステントシステム市場
• 中国の血管ステントシステム市場
• 韓国の血管ステントシステム市場
• インドネシアの血管ステントシステム市場

第10章 世界のその他地域（ROW）の血管ステントシステム市場

• 概要
• ROWの血管ステントシステム市場：タイプ別
• ROWの血管ステントシステム市場：用途別
• 中東の血管ステントシステム市場
• 南米の血管ステントシステム市場
• アフリカの血管ステントシステム市場

第11章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • 買い手の交渉力
  • 供給企業の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
• 市場シェア分析

第12章 機会と戦略分析

• バリューチェーン分析
• 成長機会分析
  • タイプ別の成長機会
  • 用途別の成長機会
• 世界の血管ステントシステム市場における新たな動向
• 戦略分析
  • 新製品開発
  • 認証とライセンシング
  • 合併、買収、契約、提携、合弁事業

第13章 バリューチェーンにおける主要企業の企業プロファイル

• 競合分析
• Boston Scientific
• Koninklijke Philips NZ
• Cook Medical
• Bentley Innomed
• Vesper Medical
• Cordis
• Abbott

第14章 付録

List of Figures

• Figure 1.1: Trends and Forecast for the Global Vascular Stent System Market
• Figure 2.1: Usage of Vascular Stent System Market
• Figure 2.2: Classification of the Global Vascular Stent System Market
• Figure 2.3: Supply Chain of the Global Vascular Stent System Market
• Figure 2.4: Driver and Challenges of the Vascular Stent System Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 4.1: Global Vascular Stent System Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Vascular Stent System Market ($B) by Type
• Figure 4.3: Forecast for the Global Vascular Stent System Market ($B) by Type
• Figure 4.4: Trends and Forecast for 60 mm in the Global Vascular Stent System Market (2019-2031)
• Figure 4.5: Trends and Forecast for 80 mm in the Global Vascular Stent System Market (2019-2031)
• Figure 4.6: Trends and Forecast for 100 mm in the Global Vascular Stent System Market (2019-2031)
• Figure 4.7: Trends and Forecast for 120 mm in the Global Vascular Stent System Market (2019-2031)
• Figure 4.8: Trends and Forecast for Others in the Global Vascular Stent System Market (2019-2031)
• Figure 5.1: Global Vascular Stent System Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Vascular Stent System Market ($B) by Application
• Figure 5.3: Forecast for the Global Vascular Stent System Market ($B) by Application
• Figure 5.4: Trends and Forecast for Veins in the Global Vascular Stent System Market (2019-2031)
• Figure 5.5: Trends and Forecast for Arteries in the Global Vascular Stent System Market (2019-2031)
• Figure 6.1: Trends of the Global Vascular Stent System Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Vascular Stent System Market ($B) by Region (2025-2031)
• Figure 7.1: Trends and Forecast for the North American Vascular Stent System Market (2019-2031)
• Figure 7.2: North American Vascular Stent System Market by Type in 2019, 2024, and 2031
• Figure 7.3: Trends of the North American Vascular Stent System Market ($B) by Type (2019-2024)
• Figure 7.4: Forecast for the North American Vascular Stent System Market ($B) by Type (2025-2031)
• Figure 7.5: North American Vascular Stent System Market by Application in 2019, 2024, and 2031
• Figure 7.6: Trends of the North American Vascular Stent System Market ($B) by Application (2019-2024)
• Figure 7.7: Forecast for the North American Vascular Stent System Market ($B) by Application (2025-2031)
• Figure 7.8: Trends and Forecast for the United States Vascular Stent System Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Mexican Vascular Stent System Market ($B) (2019-2031)
• Figure 7.10: Trends and Forecast for the Canadian Vascular Stent System Market ($B) (2019-2031)
• Figure 8.1: Trends and Forecast for the European Vascular Stent System Market (2019-2031)
• Figure 8.2: European Vascular Stent System Market by Type in 2019, 2024, and 2031
• Figure 8.3: Trends of the European Vascular Stent System Market ($B) by Type (2019-2024)
• Figure 8.4: Forecast for the European Vascular Stent System Market ($B) by Type (2025-2031)
• Figure 8.5: European Vascular Stent System Market by Application in 2019, 2024, and 2031
• Figure 8.6: Trends of the European Vascular Stent System Market ($B) by Application (2019-2024)
• Figure 8.7: Forecast for the European Vascular Stent System Market ($B) by Application (2025-2031)
• Figure 8.8: Trends and Forecast for the German Vascular Stent System Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the French Vascular Stent System Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Spanish Vascular Stent System Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the Italian Vascular Stent System Market ($B) (2019-2031)
• Figure 8.12: Trends and Forecast for the United Kingdom Vascular Stent System Market ($B) (2019-2031)
• Figure 9.1: Trends and Forecast for the APAC Vascular Stent System Market (2019-2031)
• Figure 9.2: APAC Vascular Stent System Market by Type in 2019, 2024, and 2031
• Figure 9.3: Trends of the APAC Vascular Stent System Market ($B) by Type (2019-2024)
• Figure 9.4: Forecast for the APAC Vascular Stent System Market ($B) by Type (2025-2031)
• Figure 9.5: APAC Vascular Stent System Market by Application in 2019, 2024, and 2031
• Figure 9.6: Trends of the APAC Vascular Stent System Market ($B) by Application (2019-2024)
• Figure 9.7: Forecast for the APAC Vascular Stent System Market ($B) by Application (2025-2031)
• Figure 9.8: Trends and Forecast for the Japanese Vascular Stent System Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Indian Vascular Stent System Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the Chinese Vascular Stent System Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the South Korean Vascular Stent System Market ($B) (2019-2031)
• Figure 9.12: Trends and Forecast for the Indonesian Vascular Stent System Market ($B) (2019-2031)
• Figure 10.1: Trends and Forecast for the ROW Vascular Stent System Market (2019-2031)
• Figure 10.2: ROW Vascular Stent System Market by Type in 2019, 2024, and 2031
• Figure 10.3: Trends of the ROW Vascular Stent System Market ($B) by Type (2019-2024)
• Figure 10.4: Forecast for the ROW Vascular Stent System Market ($B) by Type (2025-2031)
• Figure 10.5: ROW Vascular Stent System Market by Application in 2019, 2024, and 2031
• Figure 10.6: Trends of the ROW Vascular Stent System Market ($B) by Application (2019-2024)
• Figure 10.7: Forecast for the ROW Vascular Stent System Market ($B) by Application (2025-2031)
• Figure 10.8: Trends and Forecast for the Middle Eastern Vascular Stent System Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the South American Vascular Stent System Market ($B) (2019-2031)
• Figure 10.10: Trends and Forecast for the African Vascular Stent System Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Vascular Stent System Market
• Figure 11.2: Market Share (%) of Top Players in the Global Vascular Stent System Market (2024)
• Figure 12.1: Growth Opportunities for the Global Vascular Stent System Market by Type
• Figure 12.2: Growth Opportunities for the Global Vascular Stent System Market by Application
• Figure 12.3: Growth Opportunities for the Global Vascular Stent System Market by Region
• Figure 12.4: Emerging Trends in the Global Vascular Stent System Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Vascular Stent System Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Vascular Stent System Market by Region
• Table 1.3: Global Vascular Stent System Market Parameters and Attributes
• Table 3.1: Trends of the Global Vascular Stent System Market (2019-2024)
• Table 3.2: Forecast for the Global Vascular Stent System Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Vascular Stent System Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Vascular Stent System Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Vascular Stent System Market (2025-2031)
• Table 4.4: Trends of 60 mm in the Global Vascular Stent System Market (2019-2024)
• Table 4.5: Forecast for 60 mm in the Global Vascular Stent System Market (2025-2031)
• Table 4.6: Trends of 80 mm in the Global Vascular Stent System Market (2019-2024)
• Table 4.7: Forecast for 80 mm in the Global Vascular Stent System Market (2025-2031)
• Table 4.8: Trends of 100 mm in the Global Vascular Stent System Market (2019-2024)
• Table 4.9: Forecast for 100 mm in the Global Vascular Stent System Market (2025-2031)
• Table 4.10: Trends of 120 mm in the Global Vascular Stent System Market (2019-2024)
• Table 4.11: Forecast for 120 mm in the Global Vascular Stent System Market (2025-2031)
• Table 4.12: Trends of Others in the Global Vascular Stent System Market (2019-2024)
• Table 4.13: Forecast for Others in the Global Vascular Stent System Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Vascular Stent System Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Vascular Stent System Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Vascular Stent System Market (2025-2031)
• Table 5.4: Trends of Veins in the Global Vascular Stent System Market (2019-2024)
• Table 5.5: Forecast for Veins in the Global Vascular Stent System Market (2025-2031)
• Table 5.6: Trends of Arteries in the Global Vascular Stent System Market (2019-2024)
• Table 5.7: Forecast for Arteries in the Global Vascular Stent System Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Vascular Stent System Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Vascular Stent System Market (2025-2031)
• Table 7.1: Trends of the North American Vascular Stent System Market (2019-2024)
• Table 7.2: Forecast for the North American Vascular Stent System Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Vascular Stent System Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Vascular Stent System Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Vascular Stent System Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Vascular Stent System Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Vascular Stent System Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Vascular Stent System Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Vascular Stent System Market (2019-2031)
• Table 8.1: Trends of the European Vascular Stent System Market (2019-2024)
• Table 8.2: Forecast for the European Vascular Stent System Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Vascular Stent System Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Vascular Stent System Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Vascular Stent System Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Vascular Stent System Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Vascular Stent System Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Vascular Stent System Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Vascular Stent System Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Vascular Stent System Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Vascular Stent System Market (2019-2031)
• Table 9.1: Trends of the APAC Vascular Stent System Market (2019-2024)
• Table 9.2: Forecast for the APAC Vascular Stent System Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Vascular Stent System Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Vascular Stent System Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Vascular Stent System Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Vascular Stent System Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Vascular Stent System Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Vascular Stent System Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Vascular Stent System Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Vascular Stent System Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Vascular Stent System Market (2019-2031)
• Table 10.1: Trends of the ROW Vascular Stent System Market (2019-2024)
• Table 10.2: Forecast for the ROW Vascular Stent System Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Vascular Stent System Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Vascular Stent System Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Vascular Stent System Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Vascular Stent System Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Vascular Stent System Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Vascular Stent System Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Vascular Stent System Market (2019-2031)
• Table 11.1: Product Mapping of Vascular Stent System Suppliers Based on Segments
• Table 11.2: Operational Integration of Vascular Stent System Manufacturers
• Table 11.3: Rankings of Suppliers Based on Vascular Stent System Revenue
• Table 12.1: New Product Launches by Major Vascular Stent System Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Vascular Stent System Market

The future of the global vascular stent system market looks promising with opportunities in the veins and arteries markets. The global vascular stent system market is expected to grow with a CAGR of 6.9% from 2025 to 2031. The major drivers for this market are the rising prevalence of cardiovascular diseases, advancements in stent technology, and an aging population.

• Lucintel forecasts that, within the type category, 120mm will remain the largest segment over the forecast period because it is designed to treat larger or more complex vascular conditions requiring more extended stent placements.
• Within the application category, arteries will remain the larger segment due to transporting blood under higher pressure from the heart to the body.
• In terms of region, North America is expected to witness the highest growth over the forecast period due to the high adoption of innovative medical technologies.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Vascular Stent System Market

The global vascular stent system market is changing with technological advancements, increased demand for personalized treatments, and regulatory changes that are reshaping the landscape. These emerging trends are focused on improving patient outcomes, enhancing the efficiency of procedures, and expanding market access.

• Bioresorbable Stents: Bioresorbable stents naturally dissolve in the body after serving their purpose and are gaining traction as a leading trend. These stents obviate the need for permanent implants, which reduces complications associated with permanent stent systems. They will be one of the major players in the future of cardiovascular interventions, especially for younger patients requiring temporary vascular support. As the technology matures, bioresorbable stents will capture more market share due to the increasing demand for safer and more effective treatment options.
• Drug-Eluting Stents (DES): Drug-eluting stents (DES) are the critical development in the vascular stent market as they significantly reduce the risk of restenosis, which occurs through direct medication delivery to the artery. DES use is widespread today as they have been shown to improve the outcome for the patient and minimize follow-up procedures. As the market matures, newer DES technologies are being developed to enhance drug delivery further, reduce side effects, and extend the lifespan of the stent. This trend is expected to lead to broader adoption of DES across diverse patient populations.
• Minimally Invasive Techniques and Robotics: Minimally invasive procedures with the support of robotics and high-end imaging are changing the face of the vascular stent market. Robotic-assisted surgery offers better accuracy and precision while reducing recovery times for patients and surgical risks. These technologies make more complex cases treatable in an efficient manner and with fewer complications. As this demand continues to grow, stent systems are expected to see innovation that incorporates compatibility with robotic systems and further visual guidance technologies.
• Customized and Personalized Stent Designs: The growth in understanding vascular diseases results in the rise of custom-designed stent solutions tailored to suit the individual patients' needs. Personalized designs of stents, taking into account factors like artery size, disease progression, and health condition of the patient, are on the rise. With this, more successful results may be seen due to customized stents for distinct anatomical and clinical issues. This trend in personalized medicine is also expected to propel a lot of research into the design of patient-specific stents, which will increase the market scope.
• New Developments in Stent Materials: Material innovation is another significant trend in the vascular stent market; it is still under investigation, studying the design of biocompatible stents that would be less likely to cause complications. New materials, including biodegradable polymers and advanced alloys, are being developed to make stents better in performance and safety. The new materials have the potential to reduce restenosis rates and improve the efficiency of stents in various vascular procedures. It is expected that the use of advanced materials will enhance the long-term success and patient satisfaction of stenting procedures.

New trends, such as bioresorbable stents, drug-eluting stents, minimally invasive techniques, personalized stent designs, and improvements in the material used, are revolutionizing the vascular stent system market around the world. The new products and technologies are expected to benefit patients through improved outcomes and to increase access to stent treatment, ensuring efficient and effective treatments in healthcare delivery systems across the globe.

Recent Developments in the Vascular Stent System Market

The latest developments in the vascular stent system market reflect the trend toward advanced and patient-friendly solutions. Emphasis has been placed on developing safer, more effective, and cost-efficient stents through technological innovation, regulatory advancements, and industry partnerships.

• Advancements in Bioresorbable Stents: One of the most significant advancements in the vascular stent market is bioresorbable stents, which are absorbed by the body over time. These stents provide temporary support to blood vessels, minimize long-term complications, and reduce the need for follow-up procedures. As the technology matures and clinical results continue to show promise, bioresorbable stents are expected to capture a larger share of the market.
• Next-Generation Drug-Eluting Stents: One of the key areas is the development of next-generation drug-eluting stents (DES). These stents deliver medication directly to the affected arteries, thereby preventing restenosis and ensuring better long-term outcomes for patients. Newer DES designs include more effective drugs and polymers that enhance the stent's ability to reduce complications, making them a go-to option for patients with coronary artery disease.
• Robotic-Assisted Stent Placement: Robotic-assisted stent placement has changed the art of delivering precision and safety in stent procedures. Surgeons can now perform the implantation of stents with relative accuracy, hence lower risks for complications and shorter recovery time. As the technology is made more accessible and affordable, this medical practice is likely to take its way into many high-end facilities and many low-resource settings.
• Enhanced Regulatory Approvals: Regulatory bodies like the FDA and EMA have streamlined the approval process for innovative stent systems, allowing for quicker market entry. This regulatory support has encouraged manufacturers to develop new stent technologies that improve clinical outcomes. Faster approvals have accelerated innovation and brought advanced stent systems to patients more efficiently.
• Global Expansion of Stent Manufacturing: The expansion of stent manufacturing capabilities, especially in emerging markets, has made more affordable stent options available worldwide. Manufacturers are establishing production facilities in regions like Asia and Latin America to cater to growing local demand, increasing competition, and making high-quality stent systems more accessible to a wider patient population.

Recent advancements such as bioresorbable stents, drug-eluting stents, robotic-assisted surgery, regulatory improvements, and the expansion of manufacturing into global markets are fueling the growth of the vascular stent system market. These innovations improve the quality of patient care, increase access to treatments, and transform the future of vascular interventions.

Strategic Growth Opportunities in the Vascular Stent System Market

The vascular stent system market provides several strategic growth opportunities across applications, underlined by demand from the advance in materials, technology, and patient care. The worldwide population, which is growing, and the global population continuing to age, is also enhancing demand for products like these.

• Expansion in Emerging Markets: Emerging markets in Asia, Latin America, and Africa present massive growth opportunities for stent manufacturers. Improved healthcare access, rising cardiovascular diseases prevalence, and strong demand for vascular stents ensure an increase in growth in these areas. Large populations with less service access, on whom the companies are venturing to expand, also enhance the expansion of this market.
• Customized Stent Solutions: Advances in personalized medicine open doors for stent manufacturers to design customized stent solutions based on the specific needs of the patient. Advances in imaging technologies and 3D printing enable the production of patient-specific stents, which leads to better results and satisfaction for treatment procedures.
• Consistent with Minimally Invasive Technologies: Manufacturers will have a golden opportunity to innovate with the introduction of stent systems that integrate minimally invasive technologies, including robotic-assisted surgery and advanced imaging techniques. Such technologies provide the exact reproduction of stent placement to decrease complication rates and shorten recovery times for patients' appeal, while the healthcare providers are not left behind to have their space.
• Regenerative Medicine in Stent Design: It can lead the stent market to a more open growth stage by integrating it with vascular stent technology, regenerative medicine. The use of stem cells or bioactive substances within the design may help enhance the healing of vessels further and decrease chances of complications, such as restenosis.
• The drug-eluting and bioresorbable stents: The increasing demand for drug-eluting and bioresorbable stents is an excellent opportunity for manufacturers to focus on developing next-generation stents. These stents offer significant advantages over traditional ones, including improved efficacy, fewer complications, and better long-term patient outcomes.

Expansion opportunities in the vascular stent system market include emerging markets, personalized stent solutions, integration with minimally invasive technologies, regenerative medicine applications, and a focus on drug-eluting and bioresorbable stents. All these will be the factors driving the market forward and furthering patient care around the world.

Vascular Stent System Market Driver and Challenges

The majority of the factors in the vascular stent system market are technology-intensive, economic, and regulatory. Knowing these drivers and challenges is important for market players for the full exploitation of opportunities and the optimization of market pay-offs.

The factors responsible for driving the vascular stent system market include:

1. Technological Advancements: Major factors driving the market are continuous technological advancements in stent materials, design, and delivery mechanisms. Improved patient outcomes due to innovations like bioresorbable stents, drug-eluting stents, and robotic-assisted stent placement increase demand for more advanced solutions.

2. Increasing Prevalence of Cardiovascular Diseases: Rising cases of cardiovascular diseases, more importantly, in the aging population, are providing ample growth for vascular stents. As the incidence of heart disease continues to rise globally, the requirement for effective and reliable stent systems grows, opening a huge growth opportunity in the market.

3. Accessibility and Affordability Healthcare: Improved healthcare infrastructure, especially in emerging markets, is boosting demand for vascular stents. As healthcare becomes more accessible and affordable, more patients are able to undergo stenting procedures, driving market expansion.

4. Regulatory Approvals and Reimbursement Policies: Favorable regulatory policies and improved reimbursement systems are the most important drivers for market growth. Faster approval processes for new stent technologies and favorable reimbursement policies encourage manufacturers to introduce innovative products into the market, facilitating market expansion.

5. Increasing Focus on Minimally Invasive Procedures: The growing preference for minimally invasive procedures is another significant driver of market growth. With advantages such as shorter recovery times and fewer complications, minimally invasive stent placements are gaining popularity, contributing to the overall demand for advanced stent systems.

Challenges in the vascular stent system market are:

1. High Production Costs: The high cost of manufacturing advanced stents, particularly drug-eluting and bioresorbable stents, poses a challenge for market growth. These high production costs can limit the affordability and availability of cutting-edge stent technologies, especially in lower-income regions.

2. Regulatory Hurdles: Despite positive trends, there are challenges associated with the intricate regulatory environment across regions. The regulatory bodies demand high safety, efficacy, and quality standards, which delay the product development process and entry into the market for stent manufacturers.

3. Risk of Restenosis and Complications: Although there have been great improvements in stent technology, restenosis (re-narrowing of arteries) and other complications, such as thrombosis, remain risks associated with stent use. These challenges require ongoing innovation to develop safer, more effective stent systems.

Technological advancement in the vascular stent system is foremost, followed by an increased occurrence of cardiovascular diseases, improved health access, and favorable regulations. The major challenges that face the market are mainly production cost, regulatory hurdles, and the risk of restenosis.

List of Vascular Stent System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, vascular stent system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vascular stent system companies profiled in this report include-

• Boston Scientific
• Koninklijke Philips NV
• Cook Medical
• Bentley Innomed
• Vesper Medical
• Cordis
• Abbott

Vascular Stent System Market by Segment

The study includes a forecast for the global vascular stent system market by type, application, and region.

Vascular Stent System Market by Type [Value from 2019 to 2031]:

• 60Mm
• 80Mm
• 100Mm
• 120Mm
• Others

Vascular Stent System Market by Application [Value from 2019 to 2031]:

• Veins
• Arteries

Vascular Stent System Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Vascular Stent System Market

The global vascular stent system market has grown significantly in the last few years due to technological advancements, increasing prevalence of vascular diseases, and rising awareness about minimally invasive procedures. As medical professionals and companies focus on improving patient outcomes, innovation in stent materials, design, and delivery methods has been pivotal. The United States, China, Germany, India, and Japan are the key markets that are progressing with significant investment in research and development, along with improvements in regulations and increased healthcare infrastructure.

• United States: The vascular stent system market in the United States is growing rapidly due to advanced bioresorbable stents, which can be used temporarily to remove obstructions in blood vessels. There are various new-generation drug-eluting stents (DES) approved by the FDA, which release medication for preventing restenosis, or re-narrowing of arteries. The incidence of cardiovascular diseases is also rising, and healthcare infrastructure is improving along with reimbursement policies. In addition, the use of robotic-assisted surgeries and advanced imaging technologies has made stent placement more precise and minimally invasive.
• China: The vascular stent system market in China is growing rapidly because of the increasing incidence of cardiovascular diseases in the country and improvements in healthcare delivery. Local manufacturers are increasingly producing affordable, high-quality stents to cater to both domestic and international markets. Chinese regulators have streamlined approval processes for medical devices, encouraging innovation and entry into the market. There is a growing need for advanced stent technologies, including bioresorbable and drug-eluting stents, due to the fact that Chinese physicians are now emphasizing patient outcomes by developing individualized treatment plans. Moreover, rapid modernization in China's healthcare system will further expand these technologies.
• Germany: Germany is one of the leaders in medical technology. The country has experienced great improvements in the vascular stent system market. Drug-eluting and bioresorbable stents are among the leading products, with the leading players investing much in R&D to enhance stent performance and minimize complications. The German market benefits from the strict regulatory standards that ensure high-quality stent systems for patients. Widespread provisions under Germany's healthcare system for vascular interventions help make stent technologies more accessible. Integration of advanced imaging and robotic systems into surgery has helped the precision and efficiency of stent placement.
• India: The Indian vascular stent system market is burgeoning with rapid growth attributed to the increasing burden of cardiovascular diseases and widespread awareness of the benefits of stenting procedures. Through government initiatives and foreign investment, India has developed a competitive market for affordable stents catering to both domestic and international needs. Indian manufacturers are adopting global standards, producing high-quality stents, including drug-eluting and bioresorbable, at lower costs. In addition, improvements in the healthcare infrastructure and access to advanced technologies also increase vascular interventions within a larger population in this country.
• Japan: Vascular stent technology is one of the leaders in Japan, with thorough and consistent research and development to make these stent systems even safer and more effective. In this market, there has been massive demand for high-quality drug-eluting stents that prevent the re-narrowing of arteries after stent placement. Bioresorbable stents are another development being invested in Japan and are expected to be a big market driver. Advanced imaging techniques by Japanese healthcare providers are also utilized for finer accuracy of stent placement. The country's elderly population has been contributing to the increasing demand for efficient vascular interventions and stenting solutions.

Features of the Global Vascular Stent System Market

• Market Size Estimates: Vascular stent system market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Vascular stent system market size by type, application, and region in terms of value ($B).
• Regional Analysis: Vascular stent system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the vascular stent system market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the vascular stent system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the vascular stent system market by type (60mm, 80mm, 100mm, 120mm, and others), application (veins and arteries), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Vascular Stent System Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 60 mm: Trends and Forecast (2019-2031)
• 4.4 80 mm: Trends and Forecast (2019-2031)
• 4.5 100 mm: Trends and Forecast (2019-2031)
• 4.6 120 mm: Trends and Forecast (2019-2031)
• 4.7 Others: Trends and Forecast (2019-2031)

5. Global Vascular Stent System Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Veins: Trends and Forecast (2019-2031)
• 5.4 Arteries: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Vascular Stent System Market by Region

7. North American Vascular Stent System Market

• 7.1 Overview
• 7.2 North American Vascular Stent System Market by Type
• 7.3 North American Vascular Stent System Market by Application
• 7.4 United States Vascular Stent System Market
• 7.5 Mexican Vascular Stent System Market
• 7.6 Canadian Vascular Stent System Market

8. European Vascular Stent System Market

• 8.1 Overview
• 8.2 European Vascular Stent System Market by Type
• 8.3 European Vascular Stent System Market by Application
• 8.4 German Vascular Stent System Market
• 8.5 French Vascular Stent System Market
• 8.6 Spanish Vascular Stent System Market
• 8.7 Italian Vascular Stent System Market
• 8.8 United Kingdom Vascular Stent System Market

9. APAC Vascular Stent System Market

• 9.1 Overview
• 9.2 APAC Vascular Stent System Market by Type
• 9.3 APAC Vascular Stent System Market by Application
• 9.4 Japanese Vascular Stent System Market
• 9.5 Indian Vascular Stent System Market
• 9.6 Chinese Vascular Stent System Market
• 9.7 South Korean Vascular Stent System Market
• 9.8 Indonesian Vascular Stent System Market

10. ROW Vascular Stent System Market

• 10.1 Overview
• 10.2 ROW Vascular Stent System Market by Type
• 10.3 ROW Vascular Stent System Market by Application
• 10.4 Middle Eastern Vascular Stent System Market
• 10.5 South American Vascular Stent System Market
• 10.6 African Vascular Stent System Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Vascular Stent System Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Boston Scientific
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Koninklijke Philips NV
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Cook Medical
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Bentley Innomed
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Vesper Medical
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Cordis
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Abbott
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us